These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 27006759)
21. Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define pathology of the novel paradigm for Alzheimer's with heavy metals as primary disease cause. Cavaleri F Med Hypotheses; 2015 Dec; 85(6):779-90. PubMed ID: 26604027 [TBL] [Abstract][Full Text] [Related]
22. [The onset of psychiatric disorders and Wilson's disease]. Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784 [TBL] [Abstract][Full Text] [Related]
23. Is L-Glutamate Toxic to Neurons and Thereby Contributes to Neuronal Loss and Neurodegeneration? A Systematic Review. Al-Nasser MN; Mellor IR; Carter WG Brain Sci; 2022 Apr; 12(5):. PubMed ID: 35624964 [TBL] [Abstract][Full Text] [Related]
24. Mitochondria take center stage in aging and neurodegeneration. Beal MF Ann Neurol; 2005 Oct; 58(4):495-505. PubMed ID: 16178023 [TBL] [Abstract][Full Text] [Related]
25. Molecular diagnostics of neurodegenerative disorders. Agrawal M; Biswas A Front Mol Biosci; 2015; 2():54. PubMed ID: 26442283 [TBL] [Abstract][Full Text] [Related]
26. The Pivotal Role of Copper in Neurodegeneration: A New Strategy for the Therapy of Neurodegenerative Disorders. Giampietro R; Spinelli F; Contino M; Colabufo NA Mol Pharm; 2018 Mar; 15(3):808-820. PubMed ID: 29323501 [TBL] [Abstract][Full Text] [Related]
27. Cognitive and Physical Intervention in Metals' Dysfunction and Neurodegeneration. Jopowicz A; Wiśniowska J; Tarnacka B Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326301 [TBL] [Abstract][Full Text] [Related]
28. NADPH oxidase in brain injury and neurodegenerative disorders. Ma MW; Wang J; Zhang Q; Wang R; Dhandapani KM; Vadlamudi RK; Brann DW Mol Neurodegener; 2017 Jan; 12(1):7. PubMed ID: 28095923 [TBL] [Abstract][Full Text] [Related]
29. Biological metals and metal-targeting compounds in major neurodegenerative diseases. Barnham KJ; Bush AI Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276 [TBL] [Abstract][Full Text] [Related]
30. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics. Belaidi AA; Bush AI J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340 [TBL] [Abstract][Full Text] [Related]
31. Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Rossi L; Lombardo MF; Ciriolo MR; Rotilio G Neurochem Res; 2004 Mar; 29(3):493-504. PubMed ID: 15038597 [TBL] [Abstract][Full Text] [Related]
32. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Sas K; Robotka H; Toldi J; Vécsei L J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670 [TBL] [Abstract][Full Text] [Related]
33. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Singh A; Kukreti R; Saso L; Kukreti S Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638 [TBL] [Abstract][Full Text] [Related]
34. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders. Mattson MP Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254 [TBL] [Abstract][Full Text] [Related]